---
document_datetime: 2026-02-05 12:44:44
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/lyxumia-epar-all-authorised-presentations_en.pdf
document_name: lyxumia-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.4112678
conversion_datetime: 2026-02-09 22:30:41.446969
docling_version:
  docling-serve: 1.12.0
  docling-jobkit: 1.10.1
  docling: 2.72.0
  docling-core: 2.63.0
  docling-ibm-models: 3.11.0
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
Pack size

Content

Immediate

Route of

Pharmaceutical

Strength

(Invented)

MA (EU) Number

(concentration)

Packaging

Administration

Form name

1 pre-filled pen

3ml cartridge in pre-

Subcutaneous

Solution for

10 µg

Lyxumia

EU/1/12/811/001

filled pen use

injection

1 pre-filled pen

3ml cartridge in pre-

Subcutaneous

Solution for

20 µg

Lyxumia

EU/1/12/811/002

filled pen use

injection

2 pre-filled pens

3ml cartridge in pre-

Subcutaneous

Solution for

20 µg

Lyxumia

EU/1/12/811/003

filled pen use

injection

6 pre-filled pens

3ml cartridge in pre-

Subcutaneous

Solution for

20 µg

Lyxumia

EU/1/12/811/004

filled pen use

injection

1 pre-filled pen + 1

3ml cartridge in pre-

Subcutaneous

Solution for

10 µg + 20

Lyxumia

EU/1/12/811/005

pre-filled pen filled pen

use injection

µg

Medicinal product no longer a

1/1